Long-term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk - a cohort study of 44 494 subjects
2017 ◽
Vol 45
(9)
◽
pp. 1213-1224
◽
Keyword(s):
2002 ◽
Vol 36
(2)
◽
pp. 263-270
◽
Keyword(s):
2015 ◽
Vol 21
(46)
◽
pp. 13087
◽
2018 ◽
Vol 6
(1)
◽
pp. 1-7
◽
Keyword(s):
Keyword(s):
2003 ◽
Vol 18
(12)
◽
pp. 1345-1352
◽